| Q21245216 | A new look at an old virus: patterns of mutation accumulation in the human H1N1 influenza virus since 1918 |
| Q28732472 | A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period |
| Q62899255 | Accounting for Healthcare-Seeking Behaviours and Testing Practices in Real-Time Influenza Forecasts |
| Q30366662 | Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom. |
| Q34256945 | An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands |
| Q27312422 | An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005-2011. |
| Q55934495 | Assessing the impact of a health intervention via user-generated Internet content |
| Q30204080 | Assessing the use of hospital staff influenza-like absence (ILA) for enhancing hospital preparedness and national surveillance. |
| Q24288710 | Bayesian cohort and cross-sectional analyses of the PINCER trial: a pharmacist-led intervention to reduce medication errors in primary care |
| Q27004559 | Case fatality risk of influenza A (H1N1pdm09): a systematic review |
| Q30353609 | Clinical care for severe influenza and other severe illness in resource-limited settings: the need for evidence and guidelines. |
| Q30411896 | Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing |
| Q30367263 | Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland. |
| Q47243597 | Epidemic forecasts as a tool for public health: interpretation and (re)calibration |
| Q44389114 | Epidemiology, clinical features, and prognosis of elderly adults with severe forms of influenza A (H1N1. |
| Q36960029 | Establishing a national influenza sentinel surveillance system in a limited resource setting, experience of Sierra Leone. |
| Q28269717 | Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study |
| Q30354701 | Estimating the burden of A(H1N1)pdm09 influenza in Finland during two seasons. |
| Q36554358 | Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland |
| Q30401118 | Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage |
| Q58596733 | Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England |
| Q30357318 | Excess mortality impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in Hong Kong. |
| Q30923808 | Four key challenges in infectious disease modelling using data from multiple sources |
| Q38662482 | Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review. |
| Q26799330 | Hospitalization Fatality Risk of Influenza A(H1N1)pdm09: A Systematic Review and Meta-Analysis |
| Q30415719 | Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico |
| Q40277368 | Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B. |
| Q30427835 | Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. |
| Q30373735 | Infectious disease modeling methods as tools for informing response to novel influenza viruses of unknown pandemic potential. |
| Q33588413 | Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods |
| Q30375769 | Meta-Analysis and Potential Role of Preexisting Heterosubtypic Cellular Immunity Based on Variations in Disease Severity Outcomes for Influenza Live Viral Challenges in Humans |
| Q30571949 | Modeling seasonality in space-time infectious disease surveillance data |
| Q30367189 | Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach. |
| Q41986251 | Overcoming NS1-mediated immune antagonism involves both interferon-dependent and independent mechanisms |
| Q30431463 | Pandemic controllability: a concept to guide a proportionate and flexible operational response to future influenza pandemics. |
| Q26800248 | Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks |
| Q30414153 | Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. |
| Q30365964 | Prevalence and Mortality of Influenza A (H1N1) Virus Among Patients With Acute Respiratory Infection in Southwest Iran. |
| Q39204869 | Quantifying differences in the epidemic curves from three influenza surveillance systems: a nonlinear regression analysis |
| Q30365168 | Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore |
| Q38817437 | Retrospective forecasting of the 2010-2014 Melbourne influenza seasons using multiple surveillance systems. |
| Q30419774 | Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010 |
| Q36574319 | Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011 |
| Q28486094 | The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis |
| Q57796868 | The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis |
| Q28657934 | The spatiotemporal association of non-prescription retail sales with cases during the 2009 influenza pandemic in Great Britain |
| Q42257424 | Timely estimates of influenza A H7N9 infection severity |
| Q30224656 | Two years after pandemic influenza A/2009/H1N1: what have we learned? |
| Q31112925 | Using Combined Diagnostic Test Results to Hindcast Trends of Infection from Cross-Sectional Data. |